Bobby Okereke

Linebacker

Age: 28
Free Agency: 2027 (UFA)
Accrued Seasons: 5
  • 2024 Salary Cap Charge: $11,205,000 (4.32% of cap)
  • 2024 Cash Payout: $8,000,000 (3.37% of spending)
  • 2024 Cash to Cap Ratio: 0.71
  • Contract Value: $40,000,000 ($10,000,000 APY)
  • Fully Guaranteed Money: $21,800,000
  • Contract Ranking: 9/212 at LB

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202327$1,080,000$3,205,000$0$100,000$1,080,000$4,385,0001.9%
202428$7,900,000$3,205,000$0$100,000$7,900,000$11,205,0004.3%
2025 📝
March 20: Roster bonus due
29$5,800,000$3,205,000$3,000,000$200,000$0$12,205,0004.7%
2026 📝
March 20: Roster bonus due
30$5,800,000$3,205,000$3,000,000$200,000$0$12,205,0004.3%
Total$20,580,000$12,820,000$6,000,000$600,000$8,980,000$40,000,000

Contract Notes

Bobby Okereke signed a four year, $40 million contract with the Giants. $21.8 million of the contract is fully guaranteed. The full guarantee consists of a $12 million signing bonus and Okereke's 2023 and 2024 base salaries. If on the roster on the 5th day of the 2025 league year he will earn a $3 million roster bonus. If on the roster on the 5th day of the 2026 league year he will earn a $3 million roster bonus.

Cash Flows

- fully earned money
- unearned or partially earned money
$10M
$20M
$30M
$40M
2023202420252026
Cash Due$14,000,000$8,000,000$9,000,000$9,000,000
Running Cash$14,000,000$22,000,000$31,000,000$40,000,000
Career Earnings: $19,443,116
Career APY: $3,888,623
Potential Earnings: $45,443,116
Total Guarantees: $22,683,116
Largest Cash Payment: $14,000,000 (2023)
Largest Cap Number: $12,205,000 (2025)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
ColtsDraftedExpired20194$3,622,116$905,529$883,116$5,443,116150.3%$1,360,779
GiantsUFAActive20234$40,000,000$10,000,000$21,800,000$14,000,00035.0%$14,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Colts4$5,443,116$1,360,779$5,443,1160.0%$00.0%
Giants1$14,000,000$14,000,000$4,385,0000.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Colts$495,000$220,779$0$0$0$715,7790.3%$1,378,116
2020Colts$675,000$220,779$0$0$0$895,7790.4%$675,000
2021Colts$850,000$220,779$0$0$0$1,070,7790.6%$850,000
2022Colts$2,540,000$220,779$0$0$0$2,760,7791.3%$2,540,000
2023Giants$1,080,000$3,205,000$0$100,000$1,080,000$4,385,0001.9%$14,000,000
2024Giants$7,900,000$3,205,000$0$100,000$7,900,000$11,205,0004.3%$8,000,000
2025Giants$5,800,000$3,205,000$3,000,000$200,000$0$12,205,0004.7%$9,000,000
2026Giants$5,800,000$3,205,000$3,000,000$200,000$0$12,205,0004.3%$9,000,000
Total$25,140,000$13,703,116$6,000,000$600,000$8,980,000$45,443,116$45,443,116

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2019160045.6%39.6%4817112212002100
2020142066.4%19.9%571500416100200
2021170098.4%23.0%884219324200000
2022170085.1%35.2%975200605002200
20231700100.0%0.0%92572.52311610204000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$16,600,000$10,000,000
Injury Adjusted$16,600,000$10,000,000
test
OTC Valuation $3.1M $6.1M $9.2M $12.2M $15.3M APY $3.3M $6.7M $10M $13.3M $16.7M $4,826,000 $2,200,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.